Uniplan Investment Counsel, Inc. Psychemedics Corp Transaction History

Uniplan Investment Counsel, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$7.2 - $10.2 $701,100 - $993,224	-97,375 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.5 - $14.5 $246,658 - $376,478	-25,964 Reduced 21.05%	97,375 $982,000
Q1 2019 May 15, 2019	SELL	$13.83 - $19.63 $308,934 - $438,494	-22,338 Reduced 15.33%	123,339 $1.73 Million
Q4 2018 Feb 14, 2019	SELL	$14.15 - $18.99 $63,590 - $85,341	-4,494 Reduced 2.99%	145,677 $2.31 Million
Q3 2018 Nov 13, 2018	SELL	$18.7 - $21.72 $332,130 - $385,768	-17,761 Reduced 10.58%	150,171 $2.82 Million
Q2 2018 Aug 14, 2018	SELL	$18.55 - $21.37 $466,198 - $537,070	-25,132 Reduced 13.02%	167,932 $3.23 Million
Q1 2018 May 14, 2018	SELL	$19.52 - $22.64 $74,527 - $86,439	-3,818 Reduced 1.94%	193,064 $4.12 Million
Q4 2017 Feb 13, 2018	BUY	$16.63 - $21.24 $84,147 - $107,474	5,060 Added 2.64%	196,882 $4.05 Million
Q3 2017 Nov 14, 2017	BUY	$17.43 - $21.51 $3.34 Million - $4.13 Million	191,822	191,822 $3.54 Million

1.24M

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $13.2M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.